A nanostructure-based combined treatment for atherosclerosis
Atherosclerosis (AS) is a medical condition associated with the build-up of cholesterol plaques in the lining of arteries. These become hard and narrow and may cause heart attack or stroke. The objective of the NanoTAS project funded by the Marie Skłodowska-Curie Actions programme is to develop a novel combined treatment of AS using nano-structured agents. The approach combines thermal and mechanical treatments with targeted release of anti-AS drugs. Researchers aim to decrease the inflammation in the blood vessels, break existing atherosclerotic plaques and achieve specific drug delivery. The NanoTAS strategy is expected to achieve optimal outcome for AS patients.
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme